Oyster Point Pharma, Inc.
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
0/10
|
0 | 48.77 | -100% | -6.52 | -100% |
| P/S |
|
15.17 | 33.76 | -55.06% |
|
|
| P/BV |
|
2.95 | 4.82 | -38.81% |
|
|
| P/FCF |
|
-2.42 | 61 | -103.96% |
|
|
| Ev/Ebitda |
|
-1.99 | -22.15 | -91.02% |
|
|
| Ev/S |
|
16.62 | 22.56 | -26.33% |
|
|
| Ev/FCF |
|
-2.63 | 68.78 | -103.82% |
|
|
| E/P |
|
-0.5889 | 0.0178 | -3413.33% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
0/10
|
-809.09 | 4.98 | -16356.78% | -687.93 | +17.61% |
| ROE |
|
-306.38 | 9.61 | -3287.61% |
|
|
| ROA |
|
-65.11 | 0.3443 | -19013.06% |
|
|
| ROIC |
|
-76.56 | 7.63 | -1102.84% |
|
|
| ROS |
|
-901.02 | -25.17 | 3479.72% |
|
|
| ROCE |
|
0 | 15.35 | -100% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
10/10
|
-0.599 | -3.68 | -83.7% | -0.6833 | -12.34% |
| Nеt Debt/Ebitda |
|
0 | -3.44 | -100% |
|
|
| Debt/Ratio |
|
0.4785 | 0.1985 | 141.08% |
|
|
| Debt/Equity |
|
0 | 1.66 | -100% |
|
|
| Debt/Net Income |
|
-0.5362 | 10.32 | -105.19% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
0/10
|
0 | 0.5442 | -100% | 0 | 0% |
| Number of years of dividend growth |
|
0 | 0.7368 | -100% | ||
| DSI |
|
0 | 0.2237 | -100% |
|
|
| Average dividend growth |
|
0 | 0.9889 | -100% |
|
|
| Average percentage for 5 years |
|
0 | 0.4952 | -100% |
|
|
| Average percentage for payments |
|
0 | 43.56 | -100% |
|
|
| Difference from average difference in sector |
|
-0.5442 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
0/10
|
-21.6 | -56.89 | -62.03% | ||
| Growth impulse Ebitda in 5 years |
|
97.87 | -54.68 | -278.99% | ||
| Growth impulse Net Income in 5 years |
|
283.91 | -58.33 | -586.73% | ||
| Growth impulse FCF in 5 years |
|
1720 | -49.48 | -3576.15% | ||
| Growth impulse EPS in 5 years |
|
-50.35 | -32.41 | 55.35% |
IP Score
4.01/10
